Literature DB >> 6360898

Chemical synthesis and serology of disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy.

T Fujiwara, S W Hunter, S N Cho, G O Aspinall, P J Brennan.   

Abstract

We examined the structural requirements within the species-specific 3,6-di-O-methyl-beta-D-glucopyranosyl-(1 leads to 4)-2,3-di-O-methyl- alpha-L-rhamnopyranosyl-(1 leads to 2)-3-O-methyl-alpha-L-rhamnopyranose unit of the phenolic glycolipid I antigen of Mycobacterium leprae for binding to anti-glycolipid immunoglobulin M from human leprosy sera. We used chemically defined, partially deglycosylated fragments of phenolic glycolipid I, two other minor M. leprae-specific phenolic glycolipids (those containing 6-O-methyl-beta-D-glucopyranosyl-(1 leads to 4)-2,3-di-O-methyl-alpha- L-rhamnopyranosyl-(1 leads to 2)-3-O-methyl-alpha-L-rhamnopyranose and 3,6-di-O-methyl-beta-D-glucopyranosyl-(1 leads to 4)-3-O-methyl-alpha- L-rhamnopyranosyl-(1 leads to 2)-3-O-methyl-alpha-rhamnopyranose units), and phenolic glycolipids from other mycobacteria. Additionally, the trisaccharide of phenolic glycolipid I, the 3,6-di-O-methyl-beta-D-glucopyranosyl-(1 leads to 4)-2, 3-di-O-methyl-alpha-L-rhamnopyranose, the 6-O-methyl-beta-D-glucopyranosyl-(1 leads to 4)-2,3-di-O-methyl-alpha- L-rhamnopyranose, and the beta-D-glucopyranosyl-(1 leads to 4)-2,3-di-O-methyl-alpha- L-rhamnopyranose disaccharides were synthesized and characterized, and their activities were examined. Only the phenolic glycolipids containing 3,6-di-O-methyl-beta-D-glucopyranosyl at the nonreducing terminus were efficient in binding the anti-glycolipid immunoglobulin M, and the 3,6-di-O-methyl-beta-D-glucopyranosyl-containing di- and trisaccharides were the most effective in inhibiting this binding. Thus, the 3,6-di-O-methyl-beta-D-glucopyranosyl substituent was recognized as the primary antigen determinant in phenolic glycolipid I. With this information, bovine serum albumin containing reductively aminated 3,6-di-O-methyl-beta-D-glucopyranosyl-(1 leads to 4)-2,3-di-O-methyl- L-rhamnose was prepared and shown to be highly active in the serodiagnosis of leprosy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6360898      PMCID: PMC263417          DOI: 10.1128/iai.43.1.245-252.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  A RAPID PERMETHYLATION OF GLYCOLIPID, AND POLYSACCHARIDE CATALYZED BY METHYLSULFINYL CARBANION IN DIMETHYL SULFOXIDE.

Authors:  S HAKOMORI
Journal:  J Biochem       Date:  1964-02       Impact factor: 3.387

2.  Immunochemical relationships of certain capsular polysaccharides of Klebsiella, pneumococci and Rhizobia.

Authors:  M Heidelberger; W F Dudman; W Nimmich
Journal:  J Immunol       Date:  1970-06       Impact factor: 5.422

3.  Synthesis of the pentasaccharide chain of the Forssman antigen.

Authors:  H Paulsen; A Bünsch
Journal:  Angew Chem Int Ed Engl       Date:  1980       Impact factor: 15.336

4.  Leprosy vaccine trials to begin soon.

Authors:  T H Maugh
Journal:  Science       Date:  1982-02-26       Impact factor: 47.728

5.  Antibodies to carbohydrates: preparation of antigens by coupling carbohydrates to proteins by reductive amination with cyanoborohydride.

Authors:  G R Gray
Journal:  Methods Enzymol       Date:  1978       Impact factor: 1.600

6.  Structure of the specific oligosaccharides from the glycopeptidolipid antigens of serovars in the Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complex.

Authors:  P J Brennan; G O Aspinall; J E Shin
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

7.  Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo.

Authors:  W W Young; S I Hakomori
Journal:  Science       Date:  1981-01-30       Impact factor: 47.728

8.  A novel phenolic glycolipid from Mycobacterium leprae possibly involved in immunogenicity and pathogenicity.

Authors:  S W Hunter; P J Brennan
Journal:  J Bacteriol       Date:  1981-09       Impact factor: 3.490

9.  Structures of the glycopeptidolipid antigens from serovars in the Mycobacterium avium/Mycobacterium intracellulare/Mycobacterium scrofulaceum serocomplex.

Authors:  P J Brennan; H Mayer; G O Aspinall; J E Nam Shin
Journal:  Eur J Biochem       Date:  1981-03-16

10.  Immunological analysis of glycolipids and lipopolysaccharides derived from various mycoplasmas.

Authors:  T Sugiyama; P F Smith; T A Langworthy; W R Mayberry
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

View more
  24 in total

1.  Novel gelatin particle agglutination test for serodiagnosis of leprosy in the field.

Authors:  S Izumi; T Fujiwara; M Ikeda; Y Nishimura; K Sugiyama; K Kawatsu
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

2.  Diglycosyl diacylglycerol of Mycobacterium tuberculosis.

Authors:  S W Hunter; M R McNeil; P J Brennan
Journal:  J Bacteriol       Date:  1986-11       Impact factor: 3.490

Review 3.  Immunization against tuberculosis: what kind of vaccine?

Authors:  A J Crowle
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

Review 4.  Biological, chemical, immunological and staining properties of bacteria isolated from tissues of leprosy patients.

Authors:  C Cocito; J Delville
Journal:  Eur J Epidemiol       Date:  1985-09       Impact factor: 8.082

5.  Structure of a new glycolipid from the Mycobacterium avium-Mycobacterium intracellulare complex.

Authors:  M Watanabe; A Ohta; S i Sasaki; D E Minnikin
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

6.  Phenolic glycolipid 1 of Mycobacterium leprae causes nonspecific inflammation but has no effect on cell-mediated responses in mice.

Authors:  S J Brett; C Lowe; S N Payne; P Draper
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

7.  Cellular and humoral immune response to a phenolic glycolipid antigen (PhenGL-I) in patients with leprosy.

Authors:  F T Koster; D M Scollard; E T Umland; D B Fishbein; W C Hanly; P J Brennan; K E Nelson
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

8.  Isolation of the Mycobacterium leprae-specific glycolipid antigen, phenolic glycolipid-I, from formalin-fixed human lepromatous liver.

Authors:  S Izumi; K Sugiyama; T Fujiwara; S W Hunter; P J Brennan
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

9.  Strain variations in the murine cellular immune response to the phenolic glycolipid I antigen of Mycobacterium leprae.

Authors:  F T Koster; C Teuscher; P Matzner; E Umland; D Yanagihara; P J Brennan; K S Tung
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

10.  Specificity of a Mycobacterium kansasii phenolic glycolipid (mycoside A) immunoserum.

Authors:  F Papa; M Riviere; J J Fournié; G Puzo; H David
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.